These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31583900)

  • 1. Assessment of the "Second Day" Exercise Effect on Glycemic Control, Insulin Requirements, and CHO Intake in Type 1 Diabetes Adults.
    Müller-Korbsch M; Frühwald L; Heer M; Fangmeyer-Binder M; Reinhart-Mikocki D; Fasching P
    J Diabetes Sci Technol; 2021 Jan; 15(1):127-133. PubMed ID: 31583900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of flash glucose monitoring with real time continuous glucose monitoring in children and adolescents with type 1 diabetes treated with continuous subcutaneous insulin infusion.
    Massa GG; Gys I; Bevilacqua E; Wijnands A; Zeevaert R
    Diabetes Res Clin Pract; 2019 Jun; 152():111-118. PubMed ID: 31121275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time Lag and Accuracy of Continuous Glucose Monitoring During High Intensity Interval Training in Adults with Type 1 Diabetes.
    Li A; Riddell MC; Potashner D; Brown RE; Aronson R
    Diabetes Technol Ther; 2019 May; 21(5):286-294. PubMed ID: 31017497
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of Real-Time Continuous Glucose Monitoring Improves Glycemic Control and Other Clinical Outcomes in Type 2 Diabetes Patients Treated with Less Intensive Therapy.
    Grace T; Salyer J
    Diabetes Technol Ther; 2022 Jan; 24(1):26-31. PubMed ID: 34524013
    [No Abstract]   [Full Text] [Related]  

  • 5. The Effects of Basal Insulin Suspension at the Start of Exercise on Blood Glucose Levels During Continuous Versus Circuit-Based Exercise in Individuals with Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion.
    Zaharieva D; Yavelberg L; Jamnik V; Cinar A; Turksoy K; Riddell MC
    Diabetes Technol Ther; 2017 Jun; 19(6):370-378. PubMed ID: 28613947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of Omnipod Personalized Model Predictive Control Algorithm with Moderate Intensity Exercise in Adults with Type 1 Diabetes.
    Forlenza GP; Buckingham BA; Christiansen MP; Wadwa RP; Peyser TA; Lee JB; O'Connor J; Dassau E; Huyett LM; Layne JE; Ly TT
    Diabetes Technol Ther; 2019 May; 21(5):265-272. PubMed ID: 30925077
    [No Abstract]   [Full Text] [Related]  

  • 7. Examining the Acute Glycemic Effects of Different Types of Structured Exercise Sessions in Type 1 Diabetes in a Real-World Setting: The Type 1 Diabetes and Exercise Initiative (T1DEXI).
    Riddell MC; Li Z; Gal RL; Calhoun P; Jacobs PG; Clements MA; Martin CK; Doyle Iii FJ; Patton SR; Castle JR; Gillingham MB; Beck RW; Rickels MR;
    Diabetes Care; 2023 Apr; 46(4):704-713. PubMed ID: 36795053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbohydrate Loading Followed by High Carbohydrate Intake During Prolonged Physical Exercise and Its Impact on Glucose Control in Individuals With Diabetes Type 1-An Exploratory Study.
    Mattsson S; Jendle J; Adolfsson P
    Front Endocrinol (Lausanne); 2019; 10():571. PubMed ID: 31496994
    [No Abstract]   [Full Text] [Related]  

  • 9. No Disadvantage to Insulin Pump Off vs Pump On During Intermittent High-Intensity Exercise in Adults With Type 1 Diabetes.
    Zaharieva DP; Cinar A; Yavelberg L; Jamnik V; Riddell MC
    Can J Diabetes; 2020 Mar; 44(2):162-168. PubMed ID: 31416695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower Daily Carbohydrate Intake Is Associated With Improved Glycemic Control in Adults With Type 1 Diabetes Using a Hybrid Closed-Loop System.
    Lehmann V; Zueger T; Zeder A; Scott S; Bally L; Laimer M; Stettler C
    Diabetes Care; 2020 Dec; 43(12):3102-3105. PubMed ID: 32998989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial.
    Heinemann L; Freckmann G; Ehrmann D; Faber-Heinemann G; Guerra S; Waldenmaier D; Hermanns N
    Lancet; 2018 Apr; 391(10128):1367-1377. PubMed ID: 29459019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends of glucose, lactate and ketones during anaerobic and aerobic exercise in subjects with type 1 diabetes: The ACTION-1 study.
    De Ridder F; Ledeganck KJ; De Winter B; Braspenning R; Delbeke D; Renard E; Pozzilli P; Pieralice S; Vissers D; De Block C
    Diabetes Metab Res Rev; 2022 Sep; 38(6):e3537. PubMed ID: 35533265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artificial Pancreas With Carbohydrate Suggestion Performance for Unannounced and Announced Exercise in Type 1 Diabetes.
    Viñals C; Beneyto A; Martín-SanJosé JF; Furió-Novejarque C; Bertachi A; Bondia J; Vehi J; Conget I; Giménez M
    J Clin Endocrinol Metab; 2021 Jan; 106(1):55-63. PubMed ID: 32852548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Let the Algorithm Do the Work": Reduction of Hypoglycemia Using Sensor-Augmented Pump Therapy with Predictive Insulin Suspension (SmartGuard) in Pediatric Type 1 Diabetes Patients.
    Biester T; Kordonouri O; Holder M; Remus K; Kieninger-Baum D; Wadien T; Danne T
    Diabetes Technol Ther; 2017 Mar; 19(3):173-182. PubMed ID: 28099035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycemic Variability and Hypoglycemic Excursions With Continuous Glucose Monitoring Compared to Intermittently Scanned Continuous Glucose Monitoring in Adults With Highest Risk Type 1 Diabetes.
    Avari P; Moscardo V; Jugnee N; Oliver N; Reddy M
    J Diabetes Sci Technol; 2020 May; 14(3):567-574. PubMed ID: 31375042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective Analysis of the Impact of Commercialized Hybrid Closed-Loop System on Glycemic Control, Glycemic Variability, and Patient-Related Outcomes in Children and Adults: A Focus on Superiority Over Predictive Low-Glucose Suspend Technology.
    Beato-Víbora PI; Gallego-Gamero F; Lázaro-Martín L; Romero-Pérez MDM; Arroyo-Díez FJ
    Diabetes Technol Ther; 2020 Dec; 22(12):912-919. PubMed ID: 31855446
    [No Abstract]   [Full Text] [Related]  

  • 17. Bolus insulin dose depends on previous-day race intensity during 5 days of professional road-cycle racing in athletes with type 1 diabetes: A prospective observational study.
    Moser O; Dietrich M; McCarthy O; Bracken RM; Eckstein ML
    Diabetes Obes Metab; 2020 Oct; 22(10):1714-1721. PubMed ID: 32383791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbohydrate Requirements for Prolonged, Fasted Exercise With and Without Basal Rate Reductions in Adults With Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion.
    McGaugh SM; Zaharieva DP; Pooni R; D'Souza NC; Vienneau T; Ly TT; Riddell MC
    Diabetes Care; 2021 Feb; 44(2):610-613. PubMed ID: 33328284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of performing morning versus afternoon exercise on glycemic control and hypoglycemia frequency in type 1 diabetes patients on sensor-augmented insulin pump therapy.
    Gomez AM; Gomez C; Aschner P; Veloza A; Muñoz O; Rubio C; Vallejo S
    J Diabetes Sci Technol; 2015 May; 9(3):619-24. PubMed ID: 25555390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycemia, Treatment Satisfaction, Cognition, and Sleep Quality in Adults and Adolescents with Type 1 Diabetes When Using a Closed-Loop System Overnight Versus Sensor-Augmented Pump with Low-Glucose Suspend Function: A Randomized Crossover Study.
    Sharifi A; De Bock MI; Jayawardene D; Loh MM; Horsburgh JC; Berthold CL; Paramalingam N; Bach LA; Colman PG; Davis EA; Grosman B; Hendrieckx C; Jenkins AJ; Kumareswaran K; Kurtz N; Kyoong A; MacIsaac RJ; Speight J; Trawley S; Ward GM; Roy A; Jones TW; O'Neal DN
    Diabetes Technol Ther; 2016 Dec; 18(12):772-783. PubMed ID: 27835037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.